{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T14:09:58Z","timestamp":1767276598568,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016743","name":"Florida Agricultural and Mechanical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016743","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jdiacomp.2025.109159","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T17:27:52Z","timestamp":1756402072000},"page":"109159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trends in mean serum insulin and hyperinsulinemia among US adults without diabetes 1999\u20132018"],"prefix":"10.1016","volume":"39","author":[{"given":"Tammie M.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Churilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Centers for Disease Control and Prevention","key":"10.1016\/j.jdiacomp.2025.109159_bb0005"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0010","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1210\/jc.2003-030087","article-title":"Insulin resistance\/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease","volume":"88","author":"Reaven","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0015","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1210\/js.2019-00065","article-title":"Hyperinsulinemia: an early indicator of metabolic dysfunction","volume":"3","author":"Thomas","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0020","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1172\/JCI119628","article-title":"Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR)","volume":"100","author":"Ferrannini","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0030","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1210\/clinem\/dgab645","article-title":"Insulin resistance and cardiometabolic risk profile among nondiabetic American young adults: insights from NHANES","volume":"107","author":"Parcha","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0035","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.mcna.2011.06.002","article-title":"Insulin resistance: the link between obesity and cardiovascular disease","volume":"95","author":"Reaven","year":"2011","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1210\/jc.2004-1133","article-title":"Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis","volume":"90","author":"Ferrannini","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/met.2007.0010","article-title":"The metabolic syndrome: how definition impacts the prevalence and risk in U.S. adults: 1999\u20132004 NHANES","volume":"5","author":"Churilla","year":"2007","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0050","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1530\/EC-21-0414","article-title":"Associations between TG\/HDL ratio and insulin resistance in the US population: a cross-sectional study","volume":"10","author":"Gong","year":"2021","journal-title":"Endocr Connect"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ecl.2004.03.002","article-title":"The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals","volume":"33","author":"Reaven","year":"2004","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016554","article-title":"Association between high-fasting insulin levels and metabolic syndrome in non-diabetic middle-aged and elderly populations: a community-based study in Taiwan","volume":"8","author":"Chen","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0065","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/ATVBAHA.111.241885","article-title":"Insulin resistance and coronary heart disease in nondiabetic individuals","volume":"32","author":"Reaven","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0070","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archinte.160.8.1160","article-title":"Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study","volume":"160","author":"Lakka","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0075","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2337\/diacare.23.8.1097","article-title":"Plasma insulin and all-cause, cardiovascular, and noncardiovascular mortality: the 22-year follow-up results of the Helsinki Policemen Study","volume":"23","author":"Py\u00f6r\u00e4l\u00e4","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0080","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2337\/dc09-2110","article-title":"Insulin resistance predicts mortality in nondiabetic individuals in the U.S","volume":"33","author":"Ausk","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103264","article-title":"Hyperinsulinemia and insulin resistance in the obese may develop as part of a homeostatic response to elevated free fatty acids: a mechanistic case-control and a population-based cohort study","volume":"65","author":"Fryk","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0090","article-title":"Obesity, dyslipidemia, and cardiovascular disease: a joint expert review from the Obesity Medicine Association and the National Lipid Association 2024","volume":"10","author":"Bays","year":"2024","journal-title":"Obes Pillars"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0095","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/jpm14090980","article-title":"Patterns of lipid abnormalities in obesity: a comparative analysis in normoglycemic and prediabetic obese individuals","volume":"14","author":"Alshuweishi","year":"2024","journal-title":"J Pers Med"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0100","first-page":"1","article-title":"Prevalence of overweight, obesity, and severe obesity among adults aged 20 and over: United States, 1960\u20131962 through 2017\u20132018. Centers for Disease Control and Prevention, National Center for Health Statistics","volume":"2018","author":"Fryar","year":"2020","journal-title":"NCHS Health E-Stats"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0105","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.diabres.2014.07.010","article-title":"The triglycerides-to-HDL-cholesterol ratio and cardiovascular disease risk in obese patients with type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR)","volume":"106","author":"Eeg-Olofsson","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0110","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2021.9883","article-title":"Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999\u20132018","author":"Wang","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0115","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.2337\/dc06-0289","article-title":"Trends in hyperinsulinemia among nondiabetic adults in the U.S.","volume":"29","author":"Li","year":"2006","journal-title":"Diabetes Care"},{"author":"Centers for Disease Control and Prevention","key":"10.1016\/j.jdiacomp.2025.109159_bb0120"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0125","article-title":"National Health and Nutrition Examination Survey: plan and operations, 1999\u20132010. National Center for Health Statistics","volume":"1","author":"Zipf","year":"2013","journal-title":"Vital Health Stat"},{"author":"Centers for Disease Control and Prevention","key":"10.1016\/j.jdiacomp.2025.109159_bb0130"},{"author":"Centers for Disease Control and Prevention","key":"10.1016\/j.jdiacomp.2025.109159_bb0135"},{"author":"Centers for Disease Control and Prevention","key":"10.1016\/j.jdiacomp.2025.109159_bb0140"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0145","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/1932296818805074","article-title":"Insulin Units and Conversion Factors: A Story of Truth, Boots, and Faster Half-Truths","volume":"13","author":"Knopp","year":"2019","journal-title":"J Diabetes Sci Technol"},{"year":"2002","series-title":"Version 9.4. SAS Institute Inc","author":"SAS","key":"10.1016\/j.jdiacomp.2025.109159_bb0150"},{"year":"2012","series-title":"Version 11.0. Research Triangle Institute","author":"SAS-Callable SUDAAN","key":"10.1016\/j.jdiacomp.2025.109159_bb0155"},{"author":"National Cancer Institute","key":"10.1016\/j.jdiacomp.2025.109159_bb0160"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0165","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1210\/jc.2004-0209","article-title":"Gender differences of regional abdominal fat distribution and their relationships with insulin sensitivity in healthy and glucose-intolerant Thais","volume":"89","author":"Rattarasarn","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14093215","article-title":"Trends in hyperinsulinemia and insulin resistance among nondiabetic US adults, NHANES, 1999\u20132018","volume":"14","author":"Wu","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0175","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.2337\/dc11-2443","article-title":"Fasting insulin level is positively associated with incidence of hypertension among American young adults: a 20-year follow-up study","volume":"35","author":"Xun","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0180","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2337\/diab.45.11.1547","article-title":"Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study","volume":"45","author":"Karter","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0185","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/01.HYP.30.5.1144","article-title":"Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR)","volume":"30","author":"Ferrannini","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0190","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0026-0495(99)90195-6","article-title":"Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited","volume":"48","author":"Zavaroni","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0195","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.2337\/diacare.25.8.1358","article-title":"Serum insulin, obesity, and the incidence of type 2 diabetes in black and white adults: the atherosclerosis risk in communities study: 1987\u20131998","volume":"25","author":"Carnethon","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0200","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.amjmed.2010.08.012","article-title":"Hyperinsulinemia and the development of nonalcoholic fatty liver disease in nondiabetic adults","volume":"124","author":"Rhee","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jdiacomp.2025.109159_bb0205","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/BF00403180","article-title":"Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome","volume":"34","author":"Ferrannini","year":"1991","journal-title":"Diabetologia"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725002120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725002120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T15:58:47Z","timestamp":1760803127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872725002120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1056872725002120"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109159","relation":{},"ISSN":["1056-8727"],"issn-type":[{"type":"print","value":"1056-8727"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in mean serum insulin and hyperinsulinemia among US adults without diabetes 1999\u20132018","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"109159"}}